1-4 of 4
Santiago Montes-Moreno, MD, PhD
Close
Sort by
Journal Articles

Cell Free Tumor DNA for DLBCL Genotyping in a Phase II Randomized Trial Comparing Standard RCHOP Versus Brcap As First Line Treatment in Patients with Poor IPI DLBCL

Nerea Martinez, PhD, Sonia González de Villambrosia, MD, Ainara Pereña, Raul Tonda, Sergi Beltran, PhD, Marta Gut, PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD, Alejandro Martín, MD, Concepcion Nicolas, MD, Jose Maria Roncero, MD, Maria J. Rodriguez-Salazar, MD, Jaime Perez De Oteyza, MDPhD, Eulogio Conde, MD PhD, Eva Gonzalez-Barca, Santiago Montes-Moreno, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1676.
https://doi.org/10.1182/blood-2018-99-113757
Published: 2018
Journal Articles

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Qi Shen, Zijun Yidan Xu-Monette, PhD, Ganiraju Manyam, Carlo Visco, Alexander Tzankov, MD PhD, Xin Cao, Lijuan Deng, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William Choi, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD PhD, John P. Farnen, MD, Michael B. Møller, MD DMSc, Jane N. Winter, MD, Miguel Angel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 143.
https://doi.org/10.1182/blood.V124.21.143.143
Published: 2014
Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Ling Li, MD, Zijun Yidan Xu-Monette, PhD, Chi Young Ok, MD, Alexander Tzanko, Carlo Visco, Nora Gisin, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William W. L. Choi, MD PhD, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, Andres J.M. Ferreri, MD PhD, Michael B. Møller, MD DMSc, Ronald S. Go, MD, Jane N. Winter, MD, Miguel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1620.
https://doi.org/10.1182/blood.V124.21.1620.1620
Published: 2014
Journal Articles

MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Alexander Tzankov, MD, Yong Li, PhD, Carlo Visco, MD, Santiago Montes-Moreno, MD, PhD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, William W. L. Choi, MD, PhD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD, PhD, John P. Farnen, MD, FACP, Michael B. Moller, MD, PhD, Jane N. Winter, MD, Miguel A. Piris, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 363.
https://doi.org/10.1182/blood.V122.21.363.363
Published: 2013